Amphastar Pharmaceuticals logo
Amphastar Pharmaceuticals AMPH
€ 25.76 0.6%
report update icon

Quartalsbericht 2026-Q3
hinzugefügt 05.11.2026

Amphastar Pharmaceuticals Langfristige Verbindlichkeiten | AMPH

Langfristige Verbindlichkeiten Jährlich Amphastar Pharmaceuticals

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
682 M 671 M 648 M 118 M 122 M 70.3 M 69.4 M 42.4 M 50.1 M 37.9 M 34.7 M 44.9 M 21.8 M 24 M -

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
682 M 21.8 M 188 M

Langfristige Verbindlichkeiten Vierteljährlich Amphastar Pharmaceuticals

2026-Q3 2026-Q2 2026-Q1 2025-Q4 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
716 M 712 M 710 M 682 M 684 M 681 M 676 M 671 M 658 M 641 M 647 M 648 M 692 M 538 M 119 M 118 M 119 M 121 M 122 M 122 M 124 M 74 M 67.7 M 70.3 M 66 M 64.3 M 66.1 M 69.4 M 65.4 M 68 M 52.5 M 42.4 M 42.8 M 43.5 M 50.1 M 50.1 M 49.7 M 47 M 37.2 M 37.9 M 39.5 M 35.5 M 33.5 M 34.7 M 40.6 M 44.3 M 45.1 M 44.9 M 54.9 M 53.2 M - - - - - - - - - - - - -

Alle Zahlen in USD-Währung

Indikatorspanne aus vierteljährlicher Berichterstattung

Höchstwert Mindestwert Durchschnitt
716 M 33.5 M 234 M

Langfristige Verbindlichkeiten anderer Aktien in der Pharmaeinzelhändler

Name Langfristige Verbindlichkeiten Preis % 24h Marktkapitalisierung Land
UroGen Pharma Ltd. UroGen Pharma Ltd.
URGN
260 M $ 28.91 -8.89 % $ 1.39 B israelIsrael
Catalyst Biosciences Catalyst Biosciences
CBIO
981 K $ 13.01 0.74 % $ 1.16 B usaUSA
ARCA biopharma ARCA biopharma
ABIO
1.31 M - 1052.0 % $ 415 M usaUSA
ADiTx Therapeutics ADiTx Therapeutics
ADTX
343 K - - $ 374 usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
14 M - 5.93 % $ 314 M canadaCanada
AgeX Therapeutics AgeX Therapeutics
AGE
3.42 M - -10.17 % $ 12.2 K usaUSA
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
3.86 M - - $ 1.01 B usaUSA
AIkido Pharma AIkido Pharma
AIKI
3.49 M - 1.93 % $ 17.4 M usaUSA
Aileron Therapeutics Aileron Therapeutics
ALRN
1.06 M - 10.36 % $ 9.8 M usaUSA
AlloVir AlloVir
ALVR
33.2 M - 4.14 % $ 49.1 M usaUSA
Apellis Pharmaceuticals Apellis Pharmaceuticals
APLS
382 M - - $ 5.18 B usaUSA
Athira Pharma Athira Pharma
ATHA
16.9 M - - $ 269 M usaUSA
AVROBIO AVROBIO
AVRO
43 K - 1083.1 % $ 745 M usaUSA
AstraZeneca PLC AstraZeneca PLC
AZN
34.7 B - - $ 96.9 B britainBritain
Brainstorm Cell Therapeutics Brainstorm Cell Therapeutics
BCLI
618 K - -2.5 % $ 5.88 M usaUSA
BeiGene, Ltd. BeiGene, Ltd.
BGNE
2 B - 0.49 % $ 251 B cayman-islandsCayman-islands
EyePoint Pharmaceuticals EyePoint Pharmaceuticals
EYPT
20.9 M $ 0.23 -12.11 % $ 16.8 K usaUSA
Bio-Path Holdings Bio-Path Holdings
BPTH
434 K - - $ 100 K usaUSA
Cara Therapeutics Cara Therapeutics
CARA
85 K - -3.03 % $ 260 M usaUSA
ChromaDex Corporation ChromaDex Corporation
CDXC
9.95 M - -0.88 % $ 598 M usaUSA
Caladrius Biosciences Caladrius Biosciences
CLBS
72 K - -16.75 % $ 25.8 M usaUSA
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCC
2 K - -5.98 % $ 34.1 M usaUSA
Diffusion Pharmaceuticals Diffusion Pharmaceuticals
DFFN
480 K - 11.68 % $ 8.97 M usaUSA
Eloxx Pharmaceuticals Eloxx Pharmaceuticals
ELOX
5.24 M - -5.68 % $ 8.28 M usaUSA
Enochian Biosciences Enochian Biosciences
ENOB
56.2 K - - $ 40.5 M usaUSA
Esperion Therapeutics Esperion Therapeutics
ESPR
355 M - - $ 661 M usaUSA
Evofem Biosciences Evofem Biosciences
EVFM
4.89 M - 7.55 % $ 38.1 M usaUSA
Eyenovia Eyenovia
EYEN
8 M - 49.81 % $ 13.2 M usaUSA
FibroGen FibroGen
FGEN
85.9 M - - $ 889 M usaUSA
Homology Medicines Homology Medicines
FIXX
8.42 M - 0.77 % $ 53.4 M usaUSA
Amicus Therapeutics Amicus Therapeutics
FOLD
245 M - - $ 4.47 B usaUSA
Frequency Therapeutics Frequency Therapeutics
FREQ
50.1 M - - $ 528 M usaUSA
Galecto Galecto
GLTO
81 K - - $ 762 M danmarkDanmark
GlycoMimetics GlycoMimetics
GLYC
1.21 M - 9357.83 % $ 1.01 B usaUSA
Graybug Vision Graybug Vision
GRAY
16.4 M - -11.23 % $ 9.65 M usaUSA
Galera Therapeutics Galera Therapeutics
GRTX
152 M - -32.59 % $ 7.61 M usaUSA
Happiness Biotech Group Limited Happiness Biotech Group Limited
HAPP
1.38 M - 1.35 % $ 17.8 M chinaChina
Novavax Novavax
NVAX
844 M $ 7.47 -3.24 % $ 1.21 B usaUSA
Hepion Pharmaceuticals Hepion Pharmaceuticals
HEPA
103 K - -18.79 % $ 39.3 K usaUSA
Hoth Therapeutics Hoth Therapeutics
HOTH
2.71 K - - $ 18.8 M usaUSA
IMARA IMARA
IMRA
67 K - 15.96 % $ 663 M usaUSA
KalVista Pharmaceuticals KalVista Pharmaceuticals
KALV
110 M - - $ 1.45 B britainBritain
KemPharm KemPharm
KMPH
90.8 M - -0.34 % $ 200 M usaUSA
Kezar Life Sciences Kezar Life Sciences
KZR
5.46 M - - $ 53.3 M usaUSA
Lixte Biotechnology Holdings Lixte Biotechnology Holdings
LIXT
439 K - - $ 63.4 M usaUSA
Magenta Therapeutics Magenta Therapeutics
MGTA
6.79 M - -7.74 % $ 41.6 M usaUSA
NovaBay Pharmaceuticals NovaBay Pharmaceuticals
NBY
639 M - - $ 11.3 M usaUSA
NeuroBo Pharmaceuticals NeuroBo Pharmaceuticals
NRBO
142 K - 0.43 % $ 12 M usaUSA
OncoCyte Corporation OncoCyte Corporation
OCX
45.1 M - 17.22 % $ 355 K usaUSA
Onconova Therapeutics Onconova Therapeutics
ONTX
100 K - -0.47 % $ 21 M usaUSA